Scher HI - Search Results

1

Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial.

Logothetis CJ, Basch E, Molina A, Fizazi K, North SA, Chi KN, Jones RJ, Goodman OB, Mainwaring PN, Sternberg CN, Efstathiou E, Gagnon DD, Rothman M, Hao Y, Liu CS, Kheoh TS, Haqq CM, Scher HI, de Bono JS. Logothetis CJ, et al. Among authors: scher hi. Lancet Oncol. 2012 Dec;13(12):1210-7. doi: 10.1016/S1470-2045(12)70473-4. Epub 2012 Nov 9. Lancet Oncol. 2012. PMID: 23142059 Clinical Trial.

2

Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy.

Geller NL, Sternberg CN, Penenberg D, Scher H, Yagoda A. Geller NL, et al. Cancer. 1991 Mar 15;67(6):1525-31. doi: 10.1002/1097-0142(19910315)67:6<1525::aid-cncr2820670611>3.0.co;2-8. Cancer. 1991. PMID: 2001540

3

Phase II trial of Didemnin B in patients with advanced renal cell carcinoma.

Motzer R, Scher H, Bajorin D, Sternberg C, Bosl GJ. Motzer R, et al. Invest New Drugs. 1990 Nov;8(4):391-2. doi: 10.1007/BF00198598. Invest New Drugs. 1990. PMID: 2084073 Clinical Trial.

4

Phase II trial of trimetrexate in patients with advanced renal cell carcinoma. Clinical Community Oncology Program.

Sternberg CN, Yagoda A, Scher H, Bosl G, Dershaw D, Rosado K, Houston C, Rosenbluth R, Vinciguerra V, Boselli B. Sternberg CN, et al. Eur J Cancer Clin Oncol. 1989 Apr;25(4):753-4. doi: 10.1016/0277-5379(89)90215-0. Eur J Cancer Clin Oncol. 1989. PMID: 2523810 No abstract available.

5

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.

Sternberg CN, Yagoda A, Scher HI, Watson RC, Geller N, Herr HW, Morse MJ, Sogani PC, Vaughan ED, Bander N, et al. Sternberg CN, et al. Among authors: scher hi. Cancer. 1989 Dec 15;64(12):2448-58. doi: 10.1002/1097-0142(19891215)64:12<2448::aid-cncr2820641209>3.0.co;2-7. Cancer. 1989. PMID: 2819654

6

Chemotherapy for advanced urothelial tract tumors: the M-VAC regimen.

Sternberg CN, Yagoda A, Scher HI. Sternberg CN, et al. Among authors: scher hi. Prog Clin Biol Res. 1988;277:45-51. Prog Clin Biol Res. 1988. PMID: 3054909 Clinical Trial. No abstract available.

7

Current status of chemotherapy for urothelial tract tumors.

Sternberg CN, Scher HI. Sternberg CN, et al. Among authors: scher hi. Oncology (Williston Park). 1987 Jul;1(5):41-50, 60. Oncology (Williston Park). 1987. PMID: 3079483 Review.

8

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.

Sternberg CN, Yagoda A, Scher HI, Watson RC, Herr HW, Morse MJ, Sogani PC, Vaughan ED Jr, Bander N, Weiselberg LR, et al. Sternberg CN, et al. Among authors: scher hi. J Urol. 1988 Mar;139(3):461-9. doi: 10.1016/s0022-5347(17)42494-3. J Urol. 1988. PMID: 3343727

9

Advances in the treatment of urothelial tract tumors.

Sternberg CN, Scher HI. Sternberg CN, et al. Among authors: scher hi. Urol Clin North Am. 1987 May;14(2):373-87. Urol Clin North Am. 1987. PMID: 3554694 Review.

10

Chemotherapy of urologic malignancies.

Scher HI, Sternberg CN. Scher HI, et al. Semin Urol. 1985 Nov;3(4):239-80. Semin Urol. 1985. PMID: 3916569 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

687 results

Search Page